National and Kapodistrian University of Athens
Μόρια ρυθμιστές του κυτταρικού κύκλου στον καρκίνο της ουροδόχου κύστης
Abstract
dc:descriptionBackground: The transition from the various restrictions points of the mammalian cell cycle is coordinated by cyclin-dependent kinases (CDKs), which are devoid of enzymatic activity unless bound to their cyclin partners. The D-type Cyclins (D1, D2, D3) serve as growth factors which, in conjunction with CDK4 and CDK6 operate in mid to late G1 phase to promote progression through the G1/S restriction point, thus contributing to cell’s commitment to replicate its genome. Replication protein A (RPA) is a heterotrimer complex composed of three tightly associated subunits of 70, 32 and 14 kDa, designated as RPA1 (RPA70), RPA2 (RPA32), and RPA3 (RPA14) respectively. Current evidence appears to document RPA’s involvement in DNA damage checkpoints and also its role as a hyperphosphorylation-dependent downstream checkpoint effector for regulation of DNA metabolic pathways and all major types of DNA repair, including nucleotide excision, base excision, mismatch and double strand break repairs. Methods: Paraffin-embedded tissue from 157 patients with bladder UC was immunostained for cyclins D1, D2 and D3 as well as RPA1 and RPA2 proteins. Statistical analysis was performed in order to elucidate possible correlations with clinicopathological data and survival. Results: Cyclin D1 expression positively correlated with D2 and negatively with D3. Cyclin D1 expression decreased with increasing grade (p=0.0001) and tumour T-category in the entire cohort and in muscle-invasive carcinomas (p=0.0001 and p=0.0033). Cyclin D2 correlated with grade (p=0.0005) and T-category (p=0.0078), a relationship which remained significant in muscle-invasive (p=0.0135). Cyclin D3 immunoreactivity increased with histologic grade and T-category in the entire cohort (p=0.0001 in both relationships), in superficial (p=0.0034) and in muscle-invasive carcinomas (p=0.0036 respectively). Survival analysis in superficial tumours showed that higher cyclin D1 (p=0.0001) and higher cyclin D3 levels (p=0.0032) implied a lesser probability of survival. In muscle-invasive tumours lower cyclin D1 (p=0.0234), and D2 (p=0.0424) and higher cyclin D3 (p=0.0322) correlated with shortened survival. In multivariate analysis in superficial tumours only cyclin D3 expression remained significant. Cyclin D3 expression also retained its adverse significance in muscle-invasive tumours. RPA1 expression decreased with increasing histological grade (p= 0.0007) and T-category in the entire cohort and in muscle-invasive carcinomas (p= 0.0078 and p= 0.0135). RPA2 expression also displayed an inverse relationship with histological grade (p=0.0001) and T-category in the entire cohort and in muscle-invasive carcinomas (p=0.0001 and p=0.0120). RPA1 expression was positively correlated with RPA2 (R=0.3089, p=0.0001). Both RPA1 and RPA2 expressions were positively correlated with cyclin D1 expression (R=0.3535, p<0.0001 and R= 0.9340, p<0.0001). Survival analysis in the entire cohort showed that decreased RPA2 and RPA1 correlated with a lesser probability of survival (p<0.0001 and p=0.0181). In non muscle-invasive tumours (Ta-T1) only lower RPA2 (p=<0.0001) was proven to be correlated with shortened survival, whereas in muscle-invasive tumours (T2-T4) decreased RPA2 and RPA1 were shown to be adversely correlated with prognosis (p=0.0351 and p=0.0424). In multivariate survival analysis in the entire cohort and in non-muscle invasive cases RPA2 expression remained significant, even when adjustment for Cyclin D1 expression was applied. Conclusion: Cyclin D1 overexpression seems to be more important during early stages of bladder carcinogenesis, whereas cyclin D3 is implicated in the acquisition of a more aggressive phenotype. Cyclin D3 overexpression emerges as an independent adverse prognostic marker in both superficial and muscle-invasive tumours. Cyclin D1 is an independent indicator of shortened survival only in muscle-invasive tumours. RPA1 and RPA2 overexpression seems to be more important during early T-categories of bladder carcinogenesis. Showing similar kinetics with cyclin D1. RPA2 expression emerges as a valuable marker of favourable prognosis in the entire cohort and in non-muscle invasive tumours, supplementing the imformation obtained by standard clinicopathological prognosticators.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Levidou, Georgia
- Λεβίδου, Γεωργία
Subjects
dc:subject × 18- Κυκλίνη D1
- Κυκλίνη D2
- Κυκλίνη D3
- Ουροθηλιακό καρκίνωμα ουροδόχου κύστης
- Ανοσοϊστοχημεία
- Πρόγνωση
- Cyclin D1
- Cyclin D2
- Cyclin D3
- RPA1
- RPA2
- Urothelial bladder cancer
- Prognosis
- Immunohistochemistry ( IHC)
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25398